[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100638949":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":11,"locations":10,"responsibleParty":21,"collaborators":23,"id":29,"slug":30,"hasResults":31,"nctId":32,"briefTitle":33,"officialTitle":33,"acronym":10,"eligibilityCriteria":34,"healthyVolunteers":31,"sex":35,"minAge":36,"maxAge":10,"enrollmentInfo":37,"targetDuration":10,"studyType":40,"phases":10,"briefSummary":41,"conditions":42,"keywords":10,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":10},{"fullName":5,"class":6},"University of Calgary","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"Thyroid GuidePx® Tested Cohort",null,[12,17],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},"Elleine Allapitan","CONTACT","4032208440","elleine.allapitan@ucalgary.ca",{"name":18,"role":14,"phone":19,"phoneExt":10,"email":20},"Todd McMullen","780-407-1108","tpm1@ualberta.ca",{"type":22,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[24,27],{"name":25,"class":26},"Qualisure Diagnostics Inc.","UNKNOWN",{"name":28,"class":6},"University of Alberta","100638949","clinical-utility-of-preoperative-thyroid-guidepx-testing-100638949",false,"NCT07584447","Clinical Utility of Preoperative Thyroid GuidePx® Testing","Inclusion Criteria:\n\n* Patients aged 18 years or older at the time of enrollment\n* English-speaking\n* Bethesda V or VI cytology following FNA of a thyroid nodule (papillary thyroid cancer)\n* Bethesda III or IV with ThyroSpec positive for BRAFV600E, TERT, rearrangements in BRAF, RET, NTRK1, NTRK3, RAS + TERT, RAS + EIF1AX, AKT1, PI3CA, CTNNB1, EGFR, rearrangements in ALK\n* Tumor 1- 4cm in size\n* No lymph node involvement on ultrasound\n* No gross extrathyroidal extension on ultrasound\n\nExclusion Criteria:\n\n* Prior thyroid operation\n* Distant metastatic disease\n* Personal history of thyroid cancer\n* History of whole-body radiation exposure or radiation to the head and neck region","ALL","18 Years",{"count":38,"type":39},85,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to learn whether having Thyroid GuidePx® test results available before treatment may help patients with papillary thyroid cancer and doctors make better-informed treatment decisions.",[43,44],"Papillary Thyroid Cancer","Papillary Thyroid Carcinoma","NOT_YET_RECRUITING","2026-05-28",{"date":48,"type":49},"2026-06-01","ACTUAL",{"date":51,"type":39},"2026-04",{"date":53,"type":39},"2029-04",{"name":5,"class":6}]